Financhill
Back

Enlivex Therapeutics Quote, Financials, Valuation and Earnings

Enlivex Therapeutics Price Quote

$1.06
-0.01 (-1.85%)
(Updated: November 16, 2024 at 5:16 AM ET)

Enlivex Therapeutics Key Stats

Sell
17
Enlivex Therapeutics (ENLV) is a Sell

Day range:
$1.01 - $1.10
52-week range:
$1.01 - $4.59
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.8%

Volume:
130.4K
Avg. volume:
148.3K
1-year change:
-38.86%
Market cap:
$22.9M
Revenue:
$0
EPS:
$-1.18

How Much Does Enlivex Therapeutics Make?

Data Unavailable

Is Enlivex Therapeutics Growing As A Company?

Data Unavailable

Enlivex Therapeutics Stock Price Performance

What Is Enlivex Therapeutics 52-Week High & Low?

Enlivex Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Enlivex Therapeutics?

Is Enlivex Therapeutics Cash Flow Positive?

  • What Is ENLV Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17M
  • What Is Enlivex Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $4.9M
  • What Is Enlivex Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $12.4M

Enlivex Therapeutics Return On Invested Capital

Data Unavailable

Enlivex Therapeutics Earnings Date & Stock Price

Enlivex Therapeutics Competitors

Enlivex Therapeutics Dividend Yield

Enlivex Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -100%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 9.50
Upside from Last Price: 787.85%

Major Shareholders

  • How many ENLV shares are owned by institutional investors?
    2.5M ENLV shares are owned by institutional investors
  • How many ENLV shares are owned by insiders?
    0 ENLV shares are owned by insiders